Table 1.

Demographic/Clinical Data of Patients With AD, MCI-AD, and Healthy Controls.^a

	AD (N=30)	MCI-AD (N=29)	HC (N=30)	P Value
Sex (female)	21 (70)	15 (52)	18 (60)	ns
Age, years	71.7 ± 7.5	73.9 ± 3.9	72.3 ± 3.5	ns
MMSE	16.3 ± 4.2	24.9 ± 2.7		ns
Antidementia therapies	30 (100.0)
rivastigmine t.p. 9.5 mg/24 h	12 (40)
donepezil tablet 10 mg/day	13 (43.4)
rivastigmine t.p. 9.5 mg/24 h + memantine tablet 10 mg/day	5 (16.7)

Abbreviations: AD, Alzheimer’s disease with mild dementia; MCI-AD, mild cognitive impairment due to AD; HC, healthy controls; MMSE, Mini-Mental State Examination; ns, not significant; t.p., transdermal patch.

^aData are shown as (percentage) or arithmetic mean with standard deviation.